DVAX — Dynavax Technologies Cashflow Statement
0.000.00%
Last trade - 00:00- $1.30bn
- $911.94m
- $277.25m
- 78
- 29
- 81
- 68
Annual cashflow statement for Dynavax Technologies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -75.2 | 76.7 | 293 | -6.39 | 27.3 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 9.13 | 82.3 | 64.2 | 41.4 | 50.6 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -32.9 | 172 | -298 | 61.2 | -16 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -92.3 | 336 | 62.7 | 101 | 66.5 |
| Capital Expenditures | -11.1 | -9.48 | -7.14 | -4.1 | -6.35 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -15.5 | 23.7 | -309 | -150 | -11.7 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -26.5 | 14.2 | -316 | -154 | -18 |
| Financing Cash Flow Items | 0.672 | 0.841 | 1.43 | -4.97 | -7.55 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 109 | 55.8 | 19.5 | 1.39 | -102 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -7.79 | 404 | -234 | -51.7 | -54.4 |